1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Perspective (2016-2027)
2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Dynamic
2.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
2.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue
3.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2020
3.5 Gastrointestinal Stromal Tumor Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Stromal Tumor Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Stromal Tumor Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2022-2027)
5 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
6.2.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
6.3.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
6.4.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
7.2.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
7.3.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
7.4.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
9.2.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
9.3.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
9.4.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Yin Feng Gene
11.1.1 Yin Feng Gene Company Details
11.1.2 Yin Feng Gene Business Overview
11.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.1.4 Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.1.5 Yin Feng Gene Recent Development
11.2 KingMed
11.2.1 KingMed Company Details
11.2.2 KingMed Business Overview
11.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.2.4 KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.2.5 KingMed Recent Development
11.3 Geneis
11.3.1 Geneis Company Details
11.3.2 Geneis Business Overview
11.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.3.4 Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.3.5 Geneis Recent Development
11.4 Haplox
11.4.1 Haplox Company Details
11.4.2 Haplox Business Overview
11.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.4.4 Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.4.5 Haplox Recent Development
11.5 AmoyDX
11.5.1 AmoyDX Company Details
11.5.2 AmoyDX Business Overview
11.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.5.4 AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.5.5 AmoyDX Recent Development
11.6 Admera
11.6.1 Admera Company Details
11.6.2 Admera Business Overview
11.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.6.4 Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.6.5 Admera Recent Development
11.7 GeneChem
11.7.1 GeneChem Company Details
11.7.2 GeneChem Business Overview
11.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.7.4 GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.7.5 GeneChem Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
【免責事項】
https://www.globalresearch.jp/disclaimer